Cargando…

Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol

BACKGROUND: Over the past decade, mesenchymal stromal cells have been increasingly investigated for their therapeutic potential in several different illnesses. However, cell therapy can be limited by potentially serious adverse events including cell embolus formation and tumorigenesis. Importantly,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tieu, Alvin, Slobodian, Mitchell, Fergusson, Dean A., Montroy, Joshua, Burger, Dylan, Stewart, Duncan J., Shorr, Risa, Allan, David S., Lalu, Manoj M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909572/ https://www.ncbi.nlm.nih.gov/pubmed/31831057 http://dx.doi.org/10.1186/s13643-019-1242-y

Ejemplares similares

Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature
por: Gupta, Manika, et al.
Publicado: (2020)

Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta‐analysis
por: Tieu, Alvin, et al.
Publicado: (2021)

MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies
por: Bailey, Adrian J. M., et al.
Publicado: (2021)

Mesenchymal stromal cell‐derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application
por: Allan, David, et al.
Publicado: (2019)

Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury
por: Tieu, Alvin, et al.
Publicado: (2023)

Mesenchymal Stromal Cells As a Therapeutic Intervention for COVID-19: Second Iteration of a Living Systematic Review and Meta-Analysis
por: Kirkham, Aidan, et al.
Publicado: (2022)

Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
por: Kirkham, Aidan M., et al.
Publicado: (2023)

Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
por: Kirkham, Aidan M., et al.
Publicado: (2021)

Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19
por: Kirkham, Aidan M., et al.
Publicado: (2022)

A systematic assessment of preclinical multilaboratory studies and a comparison to single laboratory studies
por: Hunniford, Victoria T, et al.
Publicado: (2023)

Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
por: Kirkham, Aidan M, et al.
Publicado: (2022)

Definition and Characteristics of Mesenchymal Stromal Cells in Preclinical and Clinical Studies: A Scoping Review
por: Renesme, Laurent, et al.
Publicado: (2022)

Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review
por: Lalu, Manoj, et al.
Publicado: (2019)

The effects of resistant starches on inflammatory bowel disease in preclinical and clinical settings: a systematic review and meta-analysis
por: Montroy, Joshua, et al.
Publicado: (2020)

Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017)

Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review
por: Suen, Colin M., et al.
Publicado: (2019)

Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
por: McIntyre, Lauralyn A., et al.
Publicado: (2016)

Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
por: Lalu, Manoj M., et al.
Publicado: (2020)

Identifying barriers and enablers to rigorous conduct and reporting of preclinical laboratory studies
por: Lalu, Manoj M., et al.
Publicado: (2023)

A call to implement preclinical study registration in animal ethics review
por: Jeffers, Matthew S., et al.
Publicado: (2023)

Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014)

The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
por: Avey, Marc T., et al.
Publicado: (2016)

Sex-based analysis of treatment responses in animal models of sepsis: a preclinical systematic review protocol
por: Zhang, MengQi, et al.
Publicado: (2023)

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012)

Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials
por: Bastin, Donald J., et al.
Publicado: (2023)

Human endothelial colony‐forming cells in regenerative therapy: A systematic review of controlled preclinical animal studies
por: Liao, Gary, et al.
Publicado: (2020)

Patient engagement in preclinical laboratory research: A scoping review
por: Fox, Grace, et al.
Publicado: (2021)

MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol
por: Douvris, Adrianna, et al.
Publicado: (2021)

Epidemiology and reporting characteristics of preclinical systematic reviews
por: Hunniford, Victoria T., et al.
Publicado: (2021)

A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence—FAST Evidence
por: Liao, Gary, et al.
Publicado: (2020)

Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
por: Khan, Sarwat T, et al.
Publicado: (2020)

Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis
por: Xun, Chengfeng, et al.
Publicado: (2022)

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models
por: Fang, Xinru, et al.
Publicado: (2023)

The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review protocol
por: Bennett, Sean, et al.
Publicado: (2016)

Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis
por: Lalu, Manoj M., et al.
Publicado: (2019)

Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta‐Analysis
por: Lalu, Manoj M., et al.
Publicado: (2018)

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016)

A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence)
por: Zheng, Katina, et al.
Publicado: (2020)

The prevalence of patient engagement in published trials: a systematic review
por: Fergusson, Dean, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3j6v3sq4t5vrfd8p5qvh398h2a